Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.
Now is the time to launch the era of Alzheimer's disease (AD) prevention research, establish the methods and infrastructure to rapidly evaluate presymptomatic AD treatments and evaluate them rigorously and rapidly in randomized clinical trials. This article is a call to arms. It contends that the evaluation of presymptomatic AD treatments must become an urgent priority, it identifies what is holding us back and proposes new public policies and scientific strategies to overcome these roadblocks. It defines the term 'presymptomatic AD treatment', notes the best established biomarkers of AD progression and pathology and suggests how they could be used to rapidly evaluate presymptomatic AD treatments in the people at risk. It introduces an approach to evaluate presymptomatic AD treatments in asymptomatic people at the highest risk of imminent clinical onset and determines the extent to which the treatment's biomarker predicts a clinical outcome. We propose an Alzheimer's Prevention Initiative, which is now being reviewed and refined in partnership with leading academic and industry investigators. It is intended to evaluate the most promising presymptomatic AD treatments, help develop a regulatory pathway for their accelerated approval using reasonably likely surrogate end points and find demonstrably effective presymptomatic AD treatments as quickly as possible.
Reiman
Eric M
EM
The Banner Alzheimer's Institute, Phoenix, AZ 85006, USA. eric.reiman@bannerhealth.com
Langbaum
Jessica B S
JB
Tariot
Pierre N
PN
D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control*; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid; D053327:Apolipoprotein E4 / Q000235:genetics; D015415:Biomarkers / Q000134:cerebrospinal fluid; D006801:Humans; D008279:Magnetic Resonance Imaging; D018697:Nootropic Agents / Q000627:therapeutic use; D049268:Positron-Emission Tomography; D011640:Public Policy; D016032:Randomized Controlled Trials as Topic; D014481:United States; D016875:tau Proteins / Q000134:cerebrospinal fluid
D016229:Amyloid beta-Peptides; D053327:Apolipoprotein E4; D015415:Biomarkers; C054369:MAPT protein, human; D018697:Nootropic Agents; D016875:tau Proteins
Nature. 1991 Feb 21;349(6311):704-6
1671712
Brain. 2008 Jun;131(Pt 6):1630-45
18339640
Alzheimers Dement. 2008 May;4(3):171-3
18631964
Alzheimers Dement. 2005 Jul;1(1):55-66
17476317
Neuroimage. 2009 May 1;45(4):1107-16
19349228
Arch Neurol. 2007 Mar;64(3):343-9
17210801
Alzheimers Dement. 2009 Mar;5(2):81-4
19328433
Neurology. 2005 May 10;64(9):1563-72
15883317
Lancet Neurol. 2008 Feb;7(2):129-35
18191617
Neurology. 2008 Jun 10;70(24):2291-8
18509093
J Neurosci. 2006 May 31;26(22):6069-76
16738250
Neurology. 2000 Jul 12;55(1):134-6
10891924
Neuroimage. 2008 Apr 15;40(3):1214-21
18280754
Lancet Neurol. 2006 Mar;5(3):228-34
16488378
JAMA. 2008 Sep 3;300(9):1027-37
18768414
Ann N Y Acad Sci. 1996 Jan 17;777:226-32
8624089
Ann N Y Acad Sci. 2009 Oct;1180:56-67
19906261
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12145-50
19581601
NeuroRx. 2004 Apr;1(2):189-95
15717019
Alzheimers Dement. 2008 May;4(3):156-63
18631960
Neurology. 1985 Nov;35(11):1556-61
3877253
J Nucl Med. 2006 Nov;47(11):1778-86
17079810
Neurology. 2007 Aug 14;69(7):631-9
17698783
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6820-5
19346482
Lancet Neurol. 2007 Jun;6(6):494-500
17509484
Neuroimage. 2010 Jan 1;49(1):169-76
19631758
Lancet Neurol. 2006 Oct;5(10):828-34
16987729
Brain. 2008 Mar;131(Pt 3):665-80
18263627
Lancet. 2001 Jul 21;358(9277):201-5
11476837
Nature. 1995 Aug 31;376(6543):775-8
7651536
Am J Epidemiol. 2002 Jun 15;155(12):1081-7
12048221
J Nucl Med. 2009 Nov;50(11):1887-94
19837759
Arch Neurol. 2009 Dec;66(12):1469-75
20008650
Science. 1993 Aug 13;261(5123):921-3
8346443
N Engl J Med. 1996 Mar 21;334(12):752-8
8592548
J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):13-7
18931004
Arch Neurol. 2005 Dec;62(12):1881-8
16344346
JAMA. 2004 Jun 23;291(24):2947-58
15213206
JAMA. 2009 Aug 12;302(6):627-37
19671904
Neurobiol Aging. 2009 May;30(5):672-81
17920160
Neurobiol Aging. 2011 Aug;32(8):1388-99
19796846
J Neurosci. 2007 Jun 6;27(23):6174-84
17553989
JAMA. 2003 Apr 23-30;289(16):2094-103
12709467
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3334-9
11248079
JAMA. 1989 Nov 10;262(18):2551-6
2810583
J Neurol. 2009 Jun;256(6):925-32
19252791
JAMA. 2003 May 28;289(20):2651-62
12771112
Alzheimers Dement. 2009 May;5(3):234-70
19426951
Neurocase. 2005 Feb;11(1):56-64
15804925
Biol Psychiatry. 2008 Mar 15;63(6):609-18
17720148
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13203-7
16920798
Ann N Y Acad Sci. 2009 Oct;1180:28-35
19906258
Am J Psychiatry. 2007 Jun;164(6):916-21
17541051
Neurosci Lett. 1995 Feb 15;186(1):17-20
7783942
Arch Neurol. 2009 Feb;66(2):161-5
19064741
Neurodegener Dis. 2009;6(1-2):37-86
18679022
JAMA. 1995 Mar 22-29;273(12):942-7
7884953
Neurology. 2006 Mar 14;66(5):718-22
16534109
Dement Geriatr Cogn Disord. 2007;23(6):382-9
17389798
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8299-302
15932949
Neurology. 2006 Aug 8;67(3):446-52
16894106
Ann Neurol. 2003 Feb;53(2):181-8
12557284
Contemp Clin Trials. 2006 Jun;27(3):238-53
16627007
Brain. 2006 May;129(Pt 5):1240-8
16537568
Arch Gen Psychiatry. 2009 Jan;66(1):81-7
19124691
Neuroimage. 2008 Jul 15;41(4):1177-83
18486492
Am J Psychiatry. 2002 May;159(5):738-45
11986126
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7209-14
19357304
Alzheimers Dement. 2008 May;4(3):164-6
18631961
Stroke. 2006 May;37(5):1165-70
16601212
Ann Intern Med. 1996 Oct 1;125(7):605-13
8815760
Arch Neurol. 2004 Jan;61(1):82-8
14732624
J Nutr Health Aging. 2009 Mar;13(3):205-8
19262954
Biol Psychiatry. 2004 Nov 1;56(9):670-6
15522251
Neurology. 2001 Jun 12;56(11):1545-51
11402113
Neurology. 1993 Nov;43(11):2412-4
8232972
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):284-9
14688411
Alzheimer Dis Assoc Disord. 1995 Spring;9(1):17-20
7605617
Nature. 1995 Jun 29;375(6534):754-60
7596406
Am J Public Health. 1998 Sep;88(9):1337-42
9736873
Neurobiol Aging. 2008 Mar;29(3):329-40
17161508
N Engl J Med. 2000 Aug 17;343(7):450-6
10944562
Arch Neurol. 2008 Jul;65(7):896-905
18474729